# LifeCell Corporation – FDA Inspection, Sep 21, 2026

Source: https://www.keypedia.com/records/fda_inspections/lifecell-corporation/88f4f8d7-7d1a-4e6e-b3c2-96d19d3301db
Source feed: FDA_Inspections

> FDA inspection 1329332 of LifeCell Corporation, September 21, 2026. 1 citation under 21 CFR part 1271. Form 483 issued. 12 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1329332
- Company Name: LifeCell Corporation
- Inspection Date: 2026-09-21
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: New Jersey District Office
- Citation Count: 1

## Related Documents

- FDA Inspection 1230349 - 2024-05-21
- FDA Inspection 1120984 - 2020-02-20
- [FDA Inspection 1095091 - 2019-06-14](https://www.keypedia.com/records/fda_inspections/lifecell-corporation/be72417e-72ae-4bfd-b0f0-d068e8c12541)
- [FDA Inspection 1089602 - 2019-01-10](https://www.keypedia.com/records/fda_inspections/lifecell-corporation/fb559597-19ce-42e5-86ae-79a0ab93f936)
- FDA Inspection 1028651 - 2017-09-27

## Related Officers

- [Company Rep](https://www.keypedia.com/people/emily-a-walters/e80b3581-ffba-4244-9030-b6c9496da932)
- [Issuing Officer](https://www.keypedia.com/people/kish-bolden/e24957d4-927f-40c7-a7ca-860fedce2e3f)

Company: https://www.keypedia.com/companies/lifecell-corporation/befaec51-e133-4222-ad7e-0cf8e59f5d23

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248